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The induction of systemic immunosuppression fol-
lowing ultraviolet B radiation exposure has been
linked with the release of in¯ammatory and
immunomodulatory mediators by cells of the epider-
mis and dermis. Nerve growth factor has not pre-
viously been linked with ultraviolet-B-induced
immunosuppressive effects. Nerve growth factor
antibodies abrogated ultraviolet-B-induced systemic
suppression of contact hypersensitivity responses in
BALB/C mice. Subcutaneous injection of nerve
growth factor (20 mg per mouse) into dorsal skin 5 d
before hapten sensitization on ventral skin sup-
pressed contact hypersensitivity responses in mast-
cell-replete but not Wf/Wf mast-cell-depleted mice.
Nerve growth factor injected 24 h prior to challenge
was not able to suppress the efferent phase of the
contact hypersensitivity response. Subcutaneous
injection of nerve growth factor (20 mg per mouse)
did not suppress contact hypersensitivity responses in
capsaicin-pretreated (neuropeptide-depleted) BALB/c
mice, and thus sensory c-®bers are necessary for
nerve-growth-factor-mediated systemic suppression
of contact hypersensitivity responses. Increased con-
centrations of nerve growth factor within epidermal
keratinocytes 8 h after ultraviolet B irradiation were
con®rmed immunohistochemically. These ®ndings
support a role for keratinocyte-derived nerve growth
factor via its action on sensory c-®bers, and subse-
quent release of neuropeptides to mediate mast cell
degranulation in systemic suppression of contact
hypersensitivity responses in mice following ultra-
violet B exposure. Key words: rodent/sensory nerves/
skin. J Invest Dermatol 118:396±401, 2002
E
ffects of ultraviolet B (UVB) irradiation not only
include local edema and erythema but also the
systemic suppression of the immune system, with
chronic exposure leading to the initiation and
development of neoplasms normally eliminated in
immune-competent individuals (Daynes et al, 1981; Kripke,
1981; De Fabo and Noonan, 1983). Exposure of skin to UVB
in¯uences the biologic function of epidermal cells such as
keratinocytes that respond to irradiation by releasing a range of
mediators associated with in¯ammation and immune modulation
(Kim et al, 1990; Beissert and Granstein, 1996). Nerve growth
factor (NGF) is signi®cantly increased in UVB-irradiated rat
paw skin, localized within keratinocytes and single cells of the
underlying dermis (Gillardon et al, 1995). Generally noted to
promote the development, maintenance, and survival of sensory
neurons (Kaplin et al, 2000), NGF can modulate in¯ammatory
responses and act on non-neuronal cell types such as mast cells
(Horigome et al, 1993; Tal and Liberman, 1997). NGF is a
differentiation factor for the maturation of connective-tissue-
type mast cell precursors (Matsuda et al, 1991; Welker et al,
1998), and a chemoattractant and potent secretagogue for this
cell type (Horigome et al, 1993; Sawada et al, 2000).
It has been recognized for some time that UV-induced
neuropeptides and neuroendocrine hormones are involved in
cutaneous in¯ammation, in¯uencing vasodilatation and vascular
permeability (Eschenfelder et al, 1995). Recent studies have
revealed a close anatomical relationship between capsaicin-sensitive
substance P- and calcitonin gene-related peptide (CGRP)-con-
taining nerve ®bers innervating the epidermis and dermis, and
Langerhans cells, dermal mast cells, and blood vessels (Alving et al,
1991; Egan et al, 1998; Lambert and Granstein, 1998). There is
evidence that sensory c-®bers and mast cells form a functional unit
whereby stimulated nerve ®bers may activate local mast cells, which
in turn control local nerve ®ber function (Alving et al, 1991).
Substance P is a pro-in¯ammatory molecule of the tachykinin
family released from primary afferents in rat skin following UV
irradiation, and regulates local blood ¯ow, vascular permeability,
and smooth muscle tone (Lambert and Granstein, 1998). Substance
P also degranulates mast cells with histamine and leukotriene release
(Eschenfelder et al, 1995; Khalil et al, 2001). CGRP is another UV-
induced, c-®ber-derived neuropeptide that causes vasodilatation
(Lambert and Granstein, 1998), altered Langerhans cell function
(Hosoi et al, 1993), and mast cell degranulation (Piotrowski and
Foreman, 1986; Khalil et al, 2001).
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Work from this laboratory has suggested that products of dermal
mast cells have a critical role in UVB-induced systemic suppression
of contact hypersensitivity (CHS) responses in mice (Hart et al,
1997; 1998a). The dermal mast cell prevalence in the dorsal skin of
different strains of mice correlated with their susceptibility to UVB
radiation for 50% suppression of CHS responses (Hart et al, 1998a).
A functional link between mast cells and systemic suppression of
CHS responses was also demonstrated when mast-cell-depleted
mice became susceptible to immunomodulation by UVB only
upon prior reconstitution of the dorsal irradiated site with bone-
marrow-derived mast cell precursors (Hart et al, 1998a). Streilein
and colleagues have also concluded that dermal mast cell activity is
critical to UVB-induced local immunosuppression, i.e., when the
sensitizing agent is applied within 30 min to the irradiated site
(Niizeki et al, 1997; Alard et al, 1999).
The cutaneous mediators responsible for UVB-induced dermal
mast cell degranulation and subsequent systemic immunosuppres-
sion have not been fully elucidated. This study suggests that
keratinocyte-derived NGF produced maximally 8 h after irradi-
ation has an integral role in UVB-induced systemic suppression of
CHS responses, through its action on sensory c-®bers innervating
the epidermis. The release of neuropeptides in the dermis follows,
and mediates the release of mast cell products with subsequent
suppression of CHS responses.
MATERIALS AND METHODS
Animals Pathogen-free BALB/c mice (8±10 wk of age, approximately
25 g) were obtained from the Animal Resource Center of the South
Australian Department of Agriculture, Adelaide, Australia. Mice carrying
the Wf mutation on both the C57BL/6 and DBA/2 backgrounds were
originally obtained from the Walter and Eliza Hall Institute of Medical
Research (Melbourne, Australia) (Hart et al, 1998a). The homozygous
mast-cell-depleted mice (Wf/Wf) and the wild-type (+/+) were the
progeny of the mating of (C57BL/6Wf 3 DBA/2Wf) F1 hybrids, with
the Wf/Wf and +/+ mice identi®ed by coat color. For peritoneal mast
cell isolation, outbred male Sprague±Dawley rats (3 mo of age,
approximately 250 g) were used. All experiments were performed
according to the ethical guidelines of the National Health and Medical
Research Council of Australia.
NGF The 7S NGF was puri®ed from the saliva or salivary gland of
male mice as previously described (Burton et al, 1978). Brie¯y, 7S NGF
from male mouse saliva was isolated by chromatography on Sephadex G-
100 (Pharmacia, Buckinghamshire, U.K.). An extinction coef®cient of
1 mg per ml 7S NGF = 1.4 was used to calculate the 7S NGF
concentration prior to lyophilization. The 7S NGF was biologically
active in a PC-12 (neurite outgrowth) bioassay (Green and Rukenstein,
1989). The b-NGF (biologically active subunit) was puri®ed from male
mouse salivary gland homogenate using the procedure described by
Bocchini and Angeletti (1969). An extinction coef®cient of 1 mg per ml
b-NGF = 1.5 was used to calculate the b-NGF concentration prior to
lyophilization. The b-NGF was biologically active in a PC-12 bioassay
and embryonic day 8 chick dorsal root ganglion neurite outgrowth
bioassay (Levi-Montalcini, 1965). Reducing sodium dodecyl sulfate
polyacrylamide gel electrophoresis demonstrated that the purity of the
b-NGF was greater than 90%. 7S NGF (20 mg per mouse) was injected
subcutaneously (s.c.) into the dorsal neck region of mice.
Antibodies Polyclonal antibodies to b-NGF were developed in sheep
using standard immunization procedures and b-NGF, as puri®ed above,
as the antigen. Using the method of Yip et al (1984), the immune serum
neutralized endogenous NGF as judged by loss of sympathetic neurons in
the superior cervical ganglia in newborn rats that had received daily
injections for 1 wk of immune serum; rats injected with nonimmune
serum showed no loss of these sympathetic neurons. An in vitro assay
(chick dorsal root ganglion neurite outgrowth bioassay) (Levi-Montalcini,
1965) con®rmed that the antiserum neutralized the biologic activity of
b-NGF but not other neurotrophins (Fig 1). Sheep NGF immune
serum (anti-NGF) or normal sheep serum (NSS) was administered by
intraperitoneal (i.p.) injection as 10 ml per g body weight. The puri®c-
ation of the rabbit b-NGF antibody used for immunohistochemical
staining was as previously described (Conner and Varon, 1996).
UV irradiation The UV source was a bank of FS40 sunlamps
(Westinghouse, Pittsburg, PA) emitting a broad band of UV, 250±
360 nm, with 65% of the output in the UVB range (280±320 nm). A
polyvinylchloride plastic sheet was used to screen out wavelengths
< 290 nm. The dose rate (8 kJ per m2) was monitored using a UVX
radiometer with a UVX-31 sensor (Ultraviolet Products, San Gabriel,
CA). For irradiation of mice, a uniform dorsal area (8 cm2) was clean
shaven and the mice were housed in individual compartments of Perspex
cages. The sunlamps were located 20 cm above the cages.
Assay of CHS Five days after UVB irradiation on the shaved dorsum
or dorsal s.c. injection of 7S NGF, mice (®ve per group) were sensitized
on the shaved ventral skin with 100 ml of 5% 2,4,6-trinitro-
chlorobenzene (TNCB; Kasei Kogyo, Tokyo, Japan) or 3% 4-ethoxy-
methylene-2-phenyl-oxazol-5-one (oxazolone; Sigma, St. Louis, MO) in
acetone. Five days later and after coding the identities of the mouse
groups, ear thickness was measured using a micrometer (Mituoto,
Tokyo, Japan), and a CHS response was elicited by applying 10 ml of 1%
TNCB or 0.5% oxazolone in acetone to each of the ventral and dorsal
surfaces of both ears. The ear thickness was measured again 24 h after
challenge and ear swelling for each mouse was determined by subtracting
ear thickness before challenge. The mean swelling measured in mice that
were challenged, but not sensitized, with hapten (»0.03 mm) was
subtracted from this value.
Depletion of sensory neuropeptides in mice Neuropeptides in
sensory c-®bers of mice were depleted as previously described (Garssen
et al, 1998). Brie¯y, BALB/c mice at 4 wk of age were anesthetized
with i.p. injections of ketamine (75 mg per kg) and medetomidine (1 mg
per kg), and injected s.c. in the neck region with capsaicin (25 mg per
kg; Sigma) or vehicle control (alcohol:Tween 80:saline 2:1:7) in a
volume of 50 ml, on two consecutive days. Mice were not used in
experiments until 8 wk of age. After completion of CHS assays,
neuropeptide depletion was con®rmed as described previously (Garssen
et al, 1998).
Puri®cation of rat peritoneal mast cells and quantitation of
histamine release Rat peritoneal mast cells were isolated as previously
described by twice layering through 22% metrizamide gradients (Khalil
et al, 2001). Mast cells were obtained at 99% purity with > 95% viability.
The histamine released from rat peritoneal mast cells in response to
mediators was determined by ¯uorometric analysis as previously
described (Skov et al, 1985). Brie¯y, 2 3 103 peritoneal mast cells in a
Figure 1. Effect of sheep b-NGF antiserum on chick dorsal root
ganglion neurite outgrowth. Dorsal root ganglia of 8-d-old chick
embryos were dissected and cultured in the presence or absence of
b-NGF (5 ng per ml), brain-derived neurotrophic factor (BDNF, 10 ng
per ml), or neurotrophin-3 (NT3, 5 ng per ml) for 20 h in humidi®ed
air at 37°C and 5% CO2. The effect of sheep b-NGF antiserum (anti-
NGF, 1:10 dilution) on neurite outgrowth promoted by each
neurotrophin was averaged for triplicate cultures and calculated as a
percentage of that induced by neurotrophin alone. An asterisk indicates a
signi®cant reduction of neurite outgrowth by anti-NGF (p < 0.05).
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®nal volume of 200 ml Tyrodes buffer with 0.1% gelatin were incubated
with mediators for 15 min at 37°C. Substance P and compound 48/80
(48/80) were obtained from Sigma. The total histamine content was
calculated as that measured in an aliquot of boiled cells. Reactions were
stopped by centrifugation at 300 3 g, 4°C for 5 min, and 25 ml
supernatant aliquots were added to glass micro®ber-coated 96-well assay
plates (Referencelaboratoriet, Copenhagen, Denmark) for 1 h at 37°C.
Plates were then washed with distilled water and plate-bound histamine
was measured by the Referencelaboratoriet. Levels of histamine released
in response to substance P and 48/80 were corrected for spontaneous
release (i.e., that occurring in the absence of any stimulus) (Khalil et al,
2001).
Immunohistochemical staining for NGF Samples of dorsal skin
were removed from nonirradiated controls and at 4, 8, and 24 h
following UVB irradiation; they were cut into 5 mm length strips,
embedded cross-sectionally in Optimal Cutting Temperature (OCT)
compound (Tissue-Tek, Sakura Finetek U.S.A., Torrance, CA), and
stored at ±70°C. Ten micron sections were then cut, ®xed in acetone for
10 min, and incubated in NSS for 40 min at room temperature. Sections
were stained with a 1:1000 dilution of af®nity-puri®ed rabbit polyclonal
anti-b-NGF antibody (Conner and Varon, 1996) for 40 h at 4°C. After
incubation with a 1:250 dilution of a biotin-conjugated sheep antirabbit
immunoglobulin (Silenus, Hawthorn, Australia) and peroxidase-
conjugated streptavidin (1:500; Dako, Carpinteria, CA), the reaction
product was developed with 3,3¢-diaminobenzidine tetrahydrochloride
(Sigma). Sections were counterstained with a weak Lillie Mayers
hematoxylin solution (1:1). Control sections were incubated with diluted
normal rabbit serum (1:1000) or no primary antibody. For absorption of
the b-NGF antibody with solid phase antigen, 20 ml Sepharose 4B
(Pharmacia) coupled to b-NGF was added to the antiserum (1:1000) and
incubated overnight at 4°C (Rush, 1984). The supernatant was then
removed from the beads and used immediately for immunohisto-
chemistry.
Expression of results and statistical analysis A multiple comparison
procedure employing a one-way analysis of variance and Fisher's test was
used to determine the statistical signi®cance of differences among groups
of mice within CHS experiments. The data represent mean ear swelling
6 SEM of ®ve mice per group for n independent experiments. For
differences in histamine release by mast cells from different rats, a similar
analysis of variance was performed. Probabilities less than 0.05 were
considered signi®cant.
RESULTS
NGF antibodies inhibit UVB-induced systemic suppression
of CHS responses in mice BALB/c mice were administered
10 ml per g of a polyclonal sheep b-NGF antiserum (anti-NGF),
normal sheep serum (NSS), or 0.9% saline NaCl i.p. 3 h prior to
UVB irradiation. Five days later the mice were sensitized ventrally
to TNCB and a further 5 d later challenged on the ears with the
same hapten. In the CHS protocol, a change in ear swelling
provided a measure of immune function. For three experiments,
each of ®ve mice per group, UVB signi®cantly suppressed TNCB-
induced ear swelling by a mean of 48% in those mice that received
saline and 44% in those that were administered NSS (Fig 2).
Animals that received anti-NGF prior to UVB irradiation,
however, exhibited an ear swelling not signi®cantly different
from that of unirradiated control animals (Fig 2).
NGF induces systemic suppression of CHS responses in
mice BALB/c mice received either 0.9% saline or 7S NGF
(20 mg per mouse) s.c. 5 d before TNCB sensitization. For three
experiments, each of ®ve mice per group, NGF signi®cantly
suppressed TNCB-induced ear swelling by a mean of 41%
(Fig 3A). In a separate experiment, 0.9% saline or 7S NGF
(20 mg per mouse) was injected s.c. into the dorsum of BALB/c
mice presensitized 4 d earlier with TNCB. Twenty-four hours
later, the mice were challenged with the same hapten (®ve mice per
group). Hapten-induced ear swelling measured 24 h later was not
signi®cantly altered in the NGF-treated mice (Fig 3B).
Dermal mast cells are necessary for the immunosuppressive
action of NGF The involvement of dermal mast cells in NGF-
mediated systemic suppression of CHS responses in mice was next
investigated. Both mast-cell-depleted Wf/Wf and wild-type +/+
mice received either 0.9% saline or 7S NGF (20 mg per mouse) s.c.
in the dorsal skin, 5 d before TNCB or oxazolone sensitization on
their ventral surface. For experiments with both haptens (Fig 4),
NGF signi®cantly suppressed TNCB- and oxazolone-induced ear
swelling by 32% and 38%, respectively. NGF was unable to
suppress CHS responses to either hapten in the mast-cell-depleted
mice (Fig 4).
NGF in vivo provides a maintenance factor for peritoneal
mast cell degranulation in vitro Control nonirradiated rats
were administered 10 ml per g of a polyclonal sheep b-NGF
antiserum (anti-NGF), NSS, or 0.9% saline i.p. 3 h before isolation
of peritoneal mast cells. The puri®ed mast cells were incubated for
Figure 2. Effect of NGF antibodies on UVB-induced systemic
suppression of a CHS response to TNCB in BALB/c mice. Mice
received 10 ml per g polyclonal sheep antimouse b-NGF antiserum (anti-
NGF), NSS, or 0.9% saline i.p. 3 h prior to UVB irradiation (8 kJ per
m2). Five days later the mice were sensitized to TNCB. A further 5 d
later, the ears of mice were challenged with hapten and ear swelling was
determined 24 h later (three experiments, each of ®ve mice per group).
Data expressed as mean 6 SEM (n = 15). An asterisk indicates a
signi®cant suppression by UVB irradiation for mice injected with the
same solution (p < 0.05). A hash indicates a signi®cant difference for
UV-irradiated mice between those injected with the NGF antibodies and
those injected with saline or NSS (p < 0.05).
Figure 3. Role of NGF in the systemic suppression of a CHS
response in mice. (A) BALB/c mice were injected with 7S NGF
(20 mg per mouse) or an equal volume of 0.9% saline s.c. 5 d before
sensitization with TNCB (each experiment, ®ve mice per group). Mice
were challenged 5 d later with hapten and average ear swelling was
determined 24 h later. Data expressed as mean 6 SEM (n = 15). An
asterisk indicates a signi®cant suppression by NGF (p < 0.05). (B) BALB/
c mice that had been sensitized 4 d prior with TNCB were injected
with 7S NGF (20 mg per mouse) or an equal volume of 0.9% saline s.c.
(®ve mice per group). Mice were challenged after 24 h with hapten and
average ear swelling was determined 24 h later. Data expressed as mean
6 SEM (n = 5).
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15 min with buffer alone or with the mast cell degranulants, 48/80
(1 and 10 mg per ml) and substance P (100 mM). The levels of
histamine measured in the supernatants of cells from a
representative experiment are shown in Fig 5; these values have
been adjusted for spontaneous release. An equal number of
peritoneal mast cells isolated from all rats (2 3 103) contained
similar amounts of histamine as shown in the boiled samples.
Peritoneal mast cells from rats injected with the polyclonal sheep
b-NGF antiserum produced signi®cantly less histamine upon
degranulation in response to 48/80 and substance P. In a repeat
experiment, signi®cantly reduced histamine levels were again
obtained from the peritoneal mast cells from anti-NGF-treated
rats (data not shown).
Sensory c-®bers are necessary for the immunosuppressive
action of NGF Capsaicin-pretreated and control BALB/c mice
received either 0.9% saline or 7S NGF (20 mg per mouse) s.c., 5 d
before sensitization with TNCB. NGF signi®cantly suppressed ear
swelling by a mean of 48% in the control (no capsaicin) mice. NGF
was unable to signi®cantly suppress a CHS response in the
capsaicin-pretreated mice (Fig 6).
NGF expression is upregulated in murine keratinocytes
following UVB exposure The expression of endogenous NGF
in mouse epidermis at various time points following UVB
irradiation was visualized immunohistochemically. NGF
expression was upregulated in, and con®ned to, epidermal
keratinocytes following UVB exposure, and peaked 8 h after
UVB treatment (Fig 7). This staining was con®rmed to be speci®c
for NGF as the staining was not observed when the NGF antibody
was preincubated with NGF-coated Sepharose beads (Rush, 1984)
(data not shown).
DISCUSSION
This study strongly implicates NGF, sensory c-®ber-derived
neuropeptides, and mast cells in the mechanism of systemic
suppression of CHS responses in mice following UVB exposure.
NGF was ®rst implicated by the ability of NGF antibodies
administered prior to UVB irradiation to abrogate the systemic
suppression of CHS responses in mice. NGF itself was immuno-
suppressive in mice when administered in a schedule similar to that
of UVB irradiation, notably administration by s.c. injection on the
dorsum, sensitization to hapten on the ventral surface 5 d later, and
®nally challenge on the ear with the same hapten a further 5 d later.
The immunosuppressive properties of NGF were measured by a
decrease in ear swelling of mice injected with NGF 11 d previously.
NGF was without effect if administered post-sensitization prior to
challenge with hapten. NGF antibody administration to non-
irradiated rats suggested that peritoneal mast cells require
endogenous NGF as a maintenance factor for their optimal ability
to degranulate. The experiments involving NGF administration to
neuropeptide-depleted and to mast-cell-depleted mice, however,
Figure 5. Effect of NGF antibodies administered in vivo on
peritoneal mast cell degranulation in vitro. Rats were administered
10 ml per g of a polyclonal sheep b-NGF antiserum (anti-NGF), NSS or
0.9% saline i.p. 3 h before isolation of peritoneal mast cells. The puri®ed
mast cells were incubated for 15 min with buffer alone or with the mast
cell degranulants, 48/80 (1 and 10 mg per ml) and substance P (100 mM).
Histamine measured in the supernatants of 2 3 103 boiled cells indicates
total histamine content of the cells. Mean histamine levels for triplicate
incubations of cells incubated with 48/80 or substance P are shown
(+ SD) minus the mean spontaneous release measured for triplicate
incubations (18% for cells from control rat, 13% for cells from rats
administered NGF antibodies). An asterisk indicates signi®cantly lower
histamine levels from mast cells isolated from anti-NGF-treated rats
compared with histamine levels from mast cells from control or NSS-
treated rats (p < 0.05).
Figure 6. Role of neuropeptides in NGF-mediated systemic
suppression of a CHS response to TNCB in mice. Capsaicin-
pretreated and control BALB/c mice were injected with 7S NGF (20 mg
per mouse) or an equal volume of 0.9% saline s.c. 5 d before
sensitization with TNCB. Mice were challenged 5 d later with hapten
and average ear swelling was determined 24 h later. Data expressed as
mean 6 SEM (n = 10). An asterisk indicates a signi®cant suppression by
NGF in mice that were not treated with capsaicin (p < 0.05). A hash
indicates a signi®cant difference for NGF-injected mice between those
treated and those not treated with capsaicin (p < 0.05).
Figure 4. Role of mast cells in NGF-mediated systemic
suppression of a CHS response to TNCB and oxazolone in mice.
Wild-type (+/+) and mast-cell-depleted (Wf/Wf) mice were injected
with 7S NGF (20 mg per mouse) or an equal volume of 0.9% saline s.c.
5 d before sensitization with (A) TNCB or (B) oxazolone (each
experiment, ®ve mice per group). Mice were challenged 5 d later with
hapten and average ear swelling was determined 24 h later. Data
expressed as mean 6 SEM (n = 5). An asterisk indicates a signi®cant
suppression by NGF within a particular mouse strain (p < 0.05). A hash
indicates a signi®cant difference for NGF-injected mice between wild-
type and Wf/Wf mice (p < 0.05).
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con®rmed that both sensory c-®bers and mast cells were involved
in NGF-induced suppression of CHS responses in mice. The
immunohistochemical staining of UVB-exposed mouse dorsal skin
showed that NGF expression was upregulated and localized to the
epidermis following irradiation. This expression peaked at 8 h,
which supports the results of Gillardon et al (1995) who had
previously demonstrated maximal in vivo NGF expression in UV-
irradiated rat paw after 12 h. Although endogenous NGF can
provide a maintenance factor for mast cells (Fig 5) and induce
peritoneal mast cell degranulation (Horigome et al, 1993; Sawada
et al, 2000), we propose that the biologic action of UV-induced,
keratinocyte-derived NGF on dermal mast cells in vivo is indirect.
Garssen et al (1998) ®rst demonstrated that neuropeptide-depleted
mice are not susceptible to UV-induced immunosuppression, a
®nding that has been con®rmed in our laboratory with BALB/c
mice (Khalil et al, 2001). As the capsaicin-mediated depletion of
sensory c-®ber-derived neuropeptides abrogated systemic suppres-
sion of CHS responses by NGF, our data are consistent with UVB-
induced NGF (as opposed to endogenous NGF in unirradiated
skin) acting predominantly on the epidermal afferents of sensory
c-®bers innervating the skin, with subsequent release of neuropep-
tides in the dermis and mast cell degranulation. This hypothesis is
supported by the anatomical location of nerve terminals in the
epidermis, whereas mast cells in murine dermis tend to be located
distal to the epidermis in the reticular layer. In capsaicin-treated,
neuropeptide-depleted mice, UVB induction of keratinocyte NGF
expression was still observed (data not shown), suggesting that there
was no, or minimal, effect by nerves and their products on
keratinocyte NGF expression in our experimental system. This
result supports nerves as the necessary link between NGF-
expressing keratinocytes and dermal mast cells.
We propose that keratinocyte-derived NGF expressed maxim-
ally 8±12 h after UVB irradiation may be involved in a sustained
activation of sensory c-®bers for neuropeptide release. In support,
increased CGRP immunoreactivity in c-®bers has been observed
up to 48 h after UVB irradiation of rat skin (Benrath et al, 1995).
This contrasts with a more immediate effect of cis-urocanic acid
(cis-UCA) on neuropeptide-induced immunoregulation that we
propose occurs in UV-irradiated skin (Khalil et al, 2001). Trans-
UCA accounts for approximately 0.5% dry weight of the stratum
corneum, approximately 50% of which is isomerized to cis-UCA
within minutes of UVB irradiation (Noonan and De Fabo, 1992).
Our group has recently published that cis-UCA, but not trans-
UCA, perfused over a rat hind footpad blister base can stimulate the
release of the neuropeptides substance P and CGRP, which in turn
can stimulate increased blood ¯ow (Khalil et al, 2001). We
hypothesize that the cis-UCA-induced neuropeptides would also
stimulate dermal mast cell degranulation, and, in turn, systemic
suppression of CHS responses. In preliminary experiments with
cultured human keratinocytes and the murine PAM212 keratino-
cyte cell line (Yuspa et al, 1980), we have investigated a relationship
between the biologic actions of cis-UCA and keratinocyte NGF
production. In consideration of the ®nding that administration of
the NGF antibodies to mice reduced the activity of mast cells per se,
we have been unable to functionally link cis-UCA with NGF
production. At separate times after irradiation and in a potentially
unrelated fashion, we hypothesize that both cis-UCA and UV-
induced NGF independently activate sensory nerves for neuropep-
tide release, which in turn degranulates mast cells.
Mast cell degranulation has been previously implicated in models
of UV-induced ``local'' immunosuppression (Niizeki et al, 1997;
Alard et al, 1999). Those studies suggested that, within 30 min
of UVB treatment, tumor necrosis factor a released from dermal
mast cells by a CGRP-dependent mechanism downregulated
Langerhans cell function and suppressed a local CHS response.
Local immunosuppression may involve mechanisms of neuropep-
tide release that are different from those in our systemic model
(hapten applied to a nonirradiated site). As suggested by the data
above, however, UVB-induced NGF may also regulate local
immunosuppression. Via the action of UV-induced keratinocyte-
derived NGF on sensory c-®bers, CGRP and other neuropeptides
may modulate Langerhans cell function in a more sustained fashion
several hours following UV irradiation. Whereas mast-cell-derived
tumor necrosis factor a has been implicated in local immunosup-
pression following UVB irradiation (Alard et al, 1999), its role in
systemic immunosuppression is less well supported (Hart et al,
1998b; Amerio et al, 2001). We have demonstrated a critical role
for dermal mast-cell-derived histamine in UVB-induced systemic
suppression of CHS responses in mice (Hart et al, 1997, 1998a). In
contrast, a recent study identi®ed interleukin-10 from mast cells as
critical for hapten-speci®c tolerance induced by acute, low-dose
UVB radiation (Alard et al, 2001).
Mast cells have receptors for CGRP, the neuropeptide implic-
ated in UVB-induced systemic immunosuppression using systemic-
ally administered neuropeptide receptor antagonists (Garssen et al,
1998). In contrast, substance P acts on mast cells via a pertussis-
toxin-sensitive, cation-dependent, receptor-independent mechan-
ism (Columbo et al, 1996; Cocchiara et al, 1997); this may be the
Figure 7. Histologic sections of dorsal skin
stained for endogenous NGF expression. (A)
Nonirradiated control; and (B) 4 h, (C) 8 h, and
(D) 24 h following UVB irradiation.
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reason this neuropeptide has not been previously implicated in
UVB immunosuppression in studies using substance P receptor
antagonists. Although substance P is a recognized mast cell
degranulant and is released from primary afferents in rat skin
following UV irradiation (Scholzen et al, 1999; Suzuki et al, 1999),
there is evidence that this peptide can either enhance or suppress
immune function depending on the local in vivo environment
(Niizeki et al, 1999; Khalil et al, 2000).
In summary, this study reports a novel role for keratinocyte-
derived NGF in the mechanisms of systemic UVB-induced
suppression of CHS responses in mice. The data herein also
underpin the emerging importance of the nervous system in the
regulation of immune responses by implicating NGF-induced
c-®ber-derived neuropeptides in mast cell degranulation following
UVB exposure.
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